STRS Ohio’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

STRS Ohio’s Portfolio ONCT Stock Details ONCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-76	Closed	-$12K	–	2228
2019 Q1	$12K	Hold	76	–	–	﹤0.01%	2001
2018 Q4	$8K	Hold	76	–	–	﹤0.01%	2041
2018 Q3	$16K	Hold	76	–	–	﹤0.01%	2053
2018 Q2	$163K	Buy	+76	New	+$193K	﹤0.01%	1794
2014 Q2	–	Sell	-16	Closed	-$33K	–	1775
2014 Q1	$33K	Sell	16 -6	-27%	-$14.9K	﹤0.01%	1649
2013 Q4	$50K	Sell	22 -2	-8%	-$4.58K	﹤0.01%	1645
2013 Q3	$68K	Hold	24	–	–	﹤0.01%	1692
2013 Q2	$224K	Buy	+24	New	+$185K	﹤0.01%	1477

Other funds holding ONCT

AAM

Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CCM

Cohen Capital Management Corte Madera, California $735M AUM 36.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

STRS Ohio's ONCT Position: Q2 2019 in Review

STRS Ohio sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q2 2019, closing a stake of 76 shares — an estimated $12K sold.

STRS Ohio first reported a position in ONCT in Q2 2013 and held it in 8 quarters. The position peaked at $224K in Q2 2013. 24 funds tracked by Wall St. Rank hold ONCT as of Q2 2019.

STRS Ohio reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
STRS Ohio sold 76 Oncternal Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $12K.
STRS Ohio first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q2 2013 and held it in 8 quarters.
STRS Ohio's Oncternal Therapeutics, Inc. Common Stock position peaked at $224K in Q2 2013.
24 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q2 2019.

Based on STRS Ohio's 13F filing for Q2 2019, filed 25 Jul 2019.